AnPac Bio Announces Plan to Implement ADS Ratio Change
bdtonline.com
news
2022-10-18 11:33:31

PHILADELPHIA, Oct. 18, 2022 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (Nasdaq: ANPC) ('AnPac Bio' or the 'Company'), a biotechnology company with operations in the United States and China focused on early cancer screening and detection, today announced that it plans to change the ratio of the Company's American Depositary Shares ('ADSs') to its Class A ordinary shares from one (1) ADS representing one (1) Class A ordinary share to one (1) ADS representing twenty (20) Class A ordinary shares.
